Home / Tag Archives: endocrinology (page 4)

Tag Archives: endocrinology

Should Hospitalized Patients Keep Their CGMs and Insulin Pumps? The 2026 Standards Say Yes

Hospitalized patient using a continuous glucose monitor and insulin pump while reviewing glucose data on a smartphone under clinical supervision in a modern hospital room.

For years, hospital admission often meant disconnecting patients from their personal diabetes devices. Continuous glucose monitors (CGMs) and insulin pumps were frequently removed, even when patients had used them successfully at home. However, the 2026 American Diabetes Association (ADA) Standards of Care introduce a significant shift in how hospitals approach …

Read More »

Fasting or Random Glucose Testing? Navigating the New Rules for Cancer Therapy–Induced Hyperglycemia

Healthcare professional performing glucose testing on a cancer patient receiving treatment, illustrating monitoring for cancer therapy–induced hyperglycemia during oncology care.

As cancer treatment becomes increasingly sophisticated, clinicians are encountering a growing metabolic challenge. Cancer therapy–induced hyperglycemia has emerged as an important concern with the expanding use of immunotherapies and targeted therapies. In some patients, hyperglycemia develops gradually. In others, particularly those receiving immune checkpoint inhibitors, severe diabetes and diabetic ketoacidosis …

Read More »

The Diabetes Conversation Patients Don’t Want to Start: Addressing Sexual Health in Clinical Practice

Healthcare provider discussing sexual health concerns with a patient during a diabetes management consultation.

Sexual health remains one of the most overlooked aspects of diabetes management, despite its significant impact on quality of life. While clinicians routinely discuss glycemic control, cardiovascular risk, and medication adherence, conversations about sexual function are often avoided by both patients and healthcare providers. Yet sexual health concerns related to …

Read More »

The Overnight Danger Many Clinicians Miss: Why Nighttime Hypoglycemia Still Matters

Sleeping patient with diabetes beside a continuous glucose monitor showing low blood sugar levels during the night, illustrating nocturnal hypoglycemia risk.

Many healthcare providers focus heavily on daytime glucose control, yet some of the most dangerous hypoglycemic episodes occur while patients are asleep. Despite major advances in insulin therapy and glucose monitoring, nocturnal hypoglycemia remains a significant clinical concern for people living with diabetes. Because symptoms often go unnoticed during sleep, …

Read More »

Could Hearing Loss Be an Early Warning Sign of Future Diabetes Complications?

Older adult experiencing hearing difficulty alongside medical imagery of blood vessels, ear anatomy, and glucose monitoring, illustrating the connection between hearing loss and diabetes complications.

For many people living with diabetes, complications such as retinopathy, nephropathy, and neuropathy are well-recognized concerns. However, growing evidence suggests that hearing loss may deserve a place on that list as well. Researchers are increasingly examining whether hearing loss reflects the same vascular and neurologic damage that contributes to complications …

Read More »

What Your Patient’s Skin May Be Telling You About Their Diabetes Risk

Healthcare provider examining a patient with visible diabetes skin manifestations, including acanthosis nigricans, diabetic dermopathy, and other dermatologic signs associated with diabetes risk and insulin resistance.

The skin is often described as a window into overall health, and in patients with diabetes or prediabetes, it may provide some of the earliest visible signs of underlying metabolic dysfunction. While laboratory testing remains the cornerstone of diabetes diagnosis, clinicians who recognize key skin manifestations of diabetes can identify …

Read More »

When Depression Treatment Conflicts With Diabetes Management

Healthcare concept illustrating depression and diabetes management, featuring a patient experiencing emotional distress alongside diabetes monitoring supplies, medications, and a balance scale representing the challenge of balancing mental health treatment with metabolic health.

Depression and diabetes management often overlap in ways that make treatment decisions more complicated. Patients with type 2 diabetes frequently experience depression, and depression can make daily self-care harder. However, some commonly prescribed antidepressants and psychotropic medications may contribute to weight gain, worsen insulin resistance, or complicate long-term metabolic control. …

Read More »

The Corticosteroid Conundrum: Managing Steroid-Induced Hyperglycemia in Primary Care

Blood glucose monitor beside corticosteroid medication bottle and diabetes log illustrating steroid-induced diabetes management in primary care.

Patients treated with corticosteroids for asthma, COPD exacerbations, rheumatologic disease, inflammatory bowel disease, or cancer-related complications often develop significant elevations in blood glucose. In many cases, these patients have no prior history of diabetes. Yet within days of therapy initiation, blood glucose levels can rise dramatically, creating a challenging clinical …

Read More »

Diabulimia in Type 1 Diabetes: The Warning Signs Clinicians Often Miss

Young woman with type 1 diabetes appearing emotionally distressed beside diabetes supplies and healthy food, representing warning signs associated with diabulimia treatment challenges.

Patients with type 1 diabetes already face the daily burden of balancing insulin, food intake, exercise, and glucose monitoring. However, for some individuals, insulin becomes more than a treatment tool. It becomes a method for weight control. This dangerous behavior, commonly referred to as diabulimia, involves the intentional restriction or …

Read More »

Misdiagnosed as Type 2? Why We Need to Screen More Adults for LADA

Doctor explaining LADA diabetes screening to an adult patient previously diagnosed with type 2 diabetes during a clinical consultation.

Up to 10% of adults diagnosed with type 2 diabetes may actually have Latent Autoimmune Diabetes in Adults (LADA), yet many cases remain undetected for years. Because symptoms often develop slowly, LADA is frequently mistaken for traditional type 2 diabetes. However, the wrong diagnosis can delay insulin therapy, worsen glucose …

Read More »